---
$id: https://graph.org.ai/products/commodity/51143018
$type: Product
source: UNSPSC
code: "51143018"
title: "Rolziracetam"
class: "51143000"
classTitle: "Nootropics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rolziracetam

**UNSPSC Code**: 51143018
**Class**: [Nootropics](Nootropics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent with the molecular formula C7H9NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RES9I0LGG5, chemically known as 3,5-dioxopyrrolizidine but generally known as rolziracetam, which bears US NIH Compound Identifier 71893. European Medicines Agency schedules Rolziracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10370MIG. The term ROLZIRACETAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). ROLZIRACETAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rolziracetam under HS 29337900 and SITC 51561. As of Q4 2014, ROLZIRACETAM remains the US FDA Preferred Term for this commodity. Rolziracetam bears US NLM identifiers UMLS ID C0632468 and NCI Concept Code C80998. SMILES: O=C1N2C(CCC2=O)CC1.

